Supriya Srivastava

Dr. Supriya Srivastava is a Senior Researcher at the National University of Singapore, affiliated with both the Department of Medicine and the Cancer Science Institute of Singapore. With over 15 years of research experience since 2008, she has established herself as a leading researcher in gastric cancer mechanisms and biomarker discovery.

Her educational background includes:

• PhD in Pathology from King George's Medical University (2004-2007)
• M.D. in Pathology from Lala Lajpat Rai Memorial Medical College (1996-2001)

Dr. Srivastava's research focuses on gastric cancer pathogenesis, with particular emphasis on:

• Intestinal metaplasia progression to gastric cancer
• Spatial tumor heterogeneity and microenvironment
• HER2-positive gastric cancer mechanisms and resistance
• Biomarker discovery for early detection
• Molecular profiling of gastric precancerous lesions

Her extensive publication record demonstrates consistent research productivity with 91 publications accumulating 15,389 reads and 2,627 citations. Recent work has focused on spatially resolved tumor ecosystems, single-cell pharmacogenomics, and stromal phenotypes in gastric and colorectal cancers.

Dr. Srivastava's scientific achievements include:

• Third prize, FNAC of Lung in suspected malignancies (Dec 2005)
• Best Poster, Role of FNAC in Intraabdominal Pediatric neoplasm (Mar 2005)
• Certificate Honors in Social and Preventive Medicine (Apr 1999)
• Certificate Honor in Biochemistry (Jun 1997)

As a Senior Researcher, Dr. Srivastava likely supervises graduate students and junior researchers, providing mentorship in cancer biology, molecular pathology, and translational research. Her collaborative work spans multiple institutions internationally, reflecting the significance of her contributions to gastric cancer research.

Her laboratory, while not explicitly named in the available information, focuses on advanced techniques including spatial transcriptomics, single-cell analysis, and molecular profiling to understand gastric carcinogenesis and identify potential therapeutic targets.